Literature DB >> 9218650

Investigational treatments. How strict should we be?

D M Eddy1.   

Abstract

Keywords:  Biomedical and Behavioral Research; Health Care and Public Health

Mesh：

Year:  1997        PMID： 9218650     DOI： 10.1001/jama.278.3.179

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  EBM, HTA, and CER: clearing the confusion.

Authors:  Bryan R Luce; Michael Drummond; Bengt Jönsson; Peter J Neumann; J Sanford Schwartz; Uwe Siebert; Sean D Sullivan
Journal:  Milbank Q       Date:  2010-06       Impact factor: 4.911

2.  Costs of novel symptom management interventions and their impact on hospitalizations.

Authors:  Charles William Given; Cathy Bradley; Mei You; Alla Sikorskii; Barbara Given
Journal:  J Pain Symptom Manage       Date:  2010-04       Impact factor: 3.612

3.  Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina.

Authors:  Jorge F Elgart; Joaquin E Caporale; Lorena Gonzalez; Eleonora Aiello; Maximiliano Waschbusch; Juan J Gagliardino
Journal:  Health Econ Rev       Date:  2013-04-27

4.  An evaluation of the influence of the publication of the UK National Institute for health and Care Excellence's guidance on hypertension in pregnancy: a retrospective analysis of clinical practice.

Authors:  Diane Farrar; Derek Tuffnell; Trevor A Sheldon
Journal:  BMC Pregnancy Childbirth       Date:  2020-02-12       Impact factor: 3.007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.